Compare KRRO & BCBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KRRO | BCBP |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.0M | 139.1M |
| IPO Year | 2019 | 2005 |
| Metric | KRRO | BCBP |
|---|---|---|
| Price | $14.01 | $9.05 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 2 |
| Target Price | ★ $34.80 | $9.00 |
| AVG Volume (30 Days) | ★ 227.5K | 71.6K |
| Earning Date | 05-06-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 3.51% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,392,000.00 | N/A |
| Revenue This Year | N/A | $85.26 |
| Revenue Next Year | N/A | $6.14 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 181.46 | N/A |
| 52 Week Low | $5.20 | $7.31 |
| 52 Week High | $55.89 | $10.05 |
| Indicator | KRRO | BCBP |
|---|---|---|
| Relative Strength Index (RSI) | 65.53 | 68.12 |
| Support Level | $13.80 | $7.86 |
| Resistance Level | $14.96 | $9.25 |
| Average True Range (ATR) | 0.88 | 0.22 |
| MACD | 0.20 | 0.08 |
| Stochastic Oscillator | 90.36 | 84.87 |
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.
BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.